This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: Jiebin Zeng: Innovator in Pharmaceutical Chemistry
Introduction
Jiebin Zeng is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of intermediates for drug synthesis. With a total of 2 patents to his name, Zeng is recognized for his innovative approaches to chemical preparation methods.
Latest Patents
One of Jiebin Zeng's latest patents is focused on a sacubitril intermediate and its preparation method. This invention relates to a sacubitril intermediate that can be synthesized through a deprotection reaction of a compound. The disclosed intermediate serves as a raw material for synthesizing sacubitril, a medication used in treating heart failure. The method outlined in the patent boasts several advantages, including the use of easily obtainable raw materials, a simple preparation process, low cost, and environmental friendliness, making it highly suitable for industrial production.
Career Highlights
Zeng is currently employed at Sunshine Lake Pharma Co., Ltd., where he continues to advance his research and development efforts. His work in the pharmaceutical industry has positioned him as a key player in the innovation of drug synthesis processes.
Collaborations
Jiebin Zeng collaborates with several talented individuals in his field, including Lei Chen and Guodong Sun. These partnerships enhance the research and development capabilities at Sunshine Lake Pharma Co., Ltd.
Conclusion
Jiebin Zeng's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a significant inventor in the industry. His work not only advances drug synthesis methods but also emphasizes the importance of environmentally friendly practices in pharmaceutical production.